Physician profile
Jonathan E Gray
NPI 1578798054
$4,086.40
in general payments reported to CMS, 2019-2025
11 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,792 · 2020: $316 · 2021: $98.53 · 2023: $1,306 · 2024: $338 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $978 · Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $977.62 |
| Food and Beverage | $902.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,260.03 | 2019-2025 | Mako, Insignia, Triathlon |
| Amgen INC. | $153.91 | 2023-2025 | Prolia, Evenity |
| Ferring Pharmaceuticals INC. | $146.56 | 2020-2025 | Euflexxa |
| Pacira Therapeutics, INC. | $141.72 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $122.10 | 2024-2025 | Exparel, Iovera, Zilretta |
| Zimmer Biomet Holdings, INC. | $105.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $51.76 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $39.19 | 2024-2025 | |
| Boston Scientific Corporation | $34.43 | 2024 | Wavewriter Alpha Prime 16 |
| Myoscience INC. | $16.16 | 2019 | |
| Smith+Nephew, INC. | $15.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.